home · filing · 0001193125-21-287318
8-K filed September 30, 2021, 7:59 PM ET
ticker NRIX
CIK 0001549595
leadership
confidence high
sentiment neutral
materiality 0.30
Nurix Therapeutics names Judith Reinsdorf and Paul Silva to board, effective Oct 1
Nurix Therapeutics, Inc.
Judith Reinsdorf appointed to board and Governance Committee; Paul Silva to Audit Committee.
Each receives initial option to purchase 35,000 shares vesting over three years.
Reinsdorf is former EVP & GC of Johnson Controls; Silva is former SVP & CAO of Vertex.
Appointments effective Oct 1, 2021; both also receive pro-rata cash retainers.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2021-10-01
Filed September 30, 2021, 7:59 PM ET
appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021
Effective 2021-10-01
Filed September 30, 2021, 7:59 PM ET
appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Judith A. Reinsdorf was appointed as Director at Nurix Therapeutics, Inc..
Action appointed
Role Director
Exact text from the filing
appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul M. Silva was appointed as Director at Nurix Therapeutics, Inc..
Action appointed
Role Director
Exact text from the filing
appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-21-287318
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.